National Cancer Institute, Research Contracts Branch, Office of the Chief, Executive Plaza South, MSC 7222, 6120 Executive Blvd., Room 608, Bethesda, MD 20892-7222

T -- TAKING PART IN CLINICAL TRIALS SOL RFQ-80132-NE DUE 052998 POC Diane Stalder, Procurement Technician, 301/435-3803 E-MAIL: Diane Stalder, ds88b@nih.gov. Title: "Taking Part in Clinical Trials". 20 page text plus a wrap around cover. Single award for a fixed-price contract. Level 2 printing and finishing attributes are required for this specification. Reference GPO Publication 310.1 for attribute requirements. Quantity, 403,000 copies and the final films as required in the production of printing. Trim size 5-3/8" x 8- 3/8", saddle wire stitch binding along the 8-3/8" dimension. 2 sets of proofs. Provide laminated halftone dot color proofs, digital color-4000 dpi or made from final films, stripped to show the full press sheet imposition, indicating guide, gripper and ruled-up for all the bindery trim-outs of each form, plus dylux proofs, with all elements in proper position, folded and trimmed to the final size. NCI Office of Cancer Communications shall retain a complete proof set. Paper, Covers- 80 lb. white #1 dull finish cover, target brightness of 87. Text- 80 lb. white #1 dull finish text, target brightness of 87. Inks, 4 color process, Blue PMS 279, Beige 4545 and Black Ink. Solid inks required, no builds allowed. Inks shall contain minimum percentages of vegetable oil in compliance with federal procurement mandates as follows: Heat-set litho/10%, sheet-fed litho/20%, forms/20%. Coating, Overall aqueous coat, satin finish, outside cover pages 1 and 4 only. Dull varnish is acceptable as an option to aqueous coating. Margins, Bleeds follow trim marks on furnished camera copy. All responsible sources may submit a bid which shall be considered by the agency. See Numbered Note 1. No collect calls will be accepted. (0124)

Loren Data Corp. http://www.ld.com (SYN# 0088 19980506\T-0002.SOL)